21576 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being neurotensin
Enhanced in Vivo Targeting of Site-Specific Drugs
#2RADIOPHARMACEUTICALS AND METHODS OF USE THEREOF
#3Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#4Vinylsulfone-based 18F-labeling compositions and methods and uses thereof
#5Preparation of Technetium-99M Tricarbonyl Labeled Glycine Monomer or Oligomer Containing Probes That Have Biomolecules and Its Application as Imaging Complex-Composition
#6Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#7Radiofluorination method
#8Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors
#9Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1
#10Hexatriene-β-carbonyl compound
#11Enhanced ligand binding to neurotensin receptors
#12Labeled neurotensin derivatives